Insider buying last 90 days
No open-market insider purchases were filed for ISRG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ISRG insider filing, plotted on the chart in Gekko.Open ISRG in Gekko
NASDAQ: ISRG
Intuitive Surgical (ISRG) Stock Analysis & Forecast
$393.33+9.79 (+2.6%)
Close on Sep 18, 2026. Page updated Sep 19, 9:18 pm ET.
Gekko Brief
AI summaryIntuitive Surgical (ISRG) closes at $393.33, up 2.6%, sitting between its 50-day average of $373.49 and its 200-day average of $455.11. The GekkoIndex reads 53.2, placing the stock in the Neutral zone, with the reading down 10.8 over the past five sessions. Price stands 12.3% above Gekko Fair Value of $350.26. Over the past year the stock is down 9.3%, with a six-month decline of 18%.
This week's coverage centers on regulatory and product news alongside broader market moves. ISRG received a CE mark expanding its da Vinci SP single-port robot into transvaginal gynecologic procedures in Europe, building on a 2024 clearance. A separate meta-analysis covering 14 million procedures reported better perioperative outcomes for da Vinci versus laparoscopic and open surgery across 13 common conditions. Coverage also noted the company's continued investment in AI, software, and instrumentation within its surgical ecosystem, alongside broader market tailwinds from easing oil prices and lower Treasury yields.
Looking ahead, ISRG's next earnings report is scheduled for 20 October 2026 after the close, 30 days out and beyond a typical 20-trading-day holding window. The last report, on 16 July 2026, showed EPS of $2.80 against a $2.02 estimate, with an 11.2% price reaction; the company has beaten estimates in 8 of the last 8 quarters, with an average absolute reaction of 6.3%. Seasonality over the next 20 trading days has averaged -3% across 5 years, positive in just 1 of them. Analyst coverage stands at 19 buy, 3 hold, and 0 sell ratings across 22 firms, with a consensus target of $476.34.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $393.33200-day averageGekko Fair Value $350.26
Key stats
- Market cap
- $139.0B
- P/E ratio
- 43.9
- Forward P/E
- 31.7
- EPS, TTM
- $8.74
- Revenue, TTM
- $11.03B
- Profit margin
- 28.4%
- Dividend yield
- —
- Beta
- 1.47
- Volume
- 4.78M avg 2.29M
- 1-year return
- −9.3%
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±6.3%
- 50-day average
- $373.49
- 200-day average
- $455.11
- Next earnings
- Oct 20 after close
- Shares outstanding
- 358.3M
Intuitive Surgical swing-trade checklist
Intuitive Surgical scores 1 supportive, 2 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed2 headwinds
- Trendmixed
Averages disagree
Close $393.33 sits between the 50-day ($373.49) and 200-day ($455.11) averages, or the averages disagree.
See the chart - GekkoIndexmixed
53.2, Neutral
Reading 53.2 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
12.3% above
Price is 12.3% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 20, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−3.0% on average
From this point in the calendar, the next 20 trading days averaged −3% over 5 years, rising in 1 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Intuitive Surgical stock chart and price history
Intuitive Surgical closed at $393.33 on Sep 18, 2026, −9.3% over the past year, inside a 52-week range of $328.57 to $603.88.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −1.1%
- 3 months
- −3.3%
- 6 months
- −18.0%
- 1 year
- −9.3%
The full ISRG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ISRG in Gekko
Follow Intuitive Surgical through every session
Put ISRG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ISRG in GekkoFree for 7 days. No credit card required.
About Intuitive Surgical
Intuitive Surgical designs, builds, and sells advanced medical devices aimed at making surgery less invasive for patients. Its best-known product is the da Vinci Surgical System, used to perform complex procedures through small incisions. The company also makes the Ion endoluminal system, which supports diagnostic work such as minimally invasive lung biopsies.
Beyond its two core systems, the company sells related instruments like staplers, energy devices, and other core components used alongside its equipment. It also provides training so medical staff can operate its technology properly, along with ongoing support such as installation, repair, and maintenance services. In addition, it builds digital tools meant to connect its systems and give hospitals data to help run more efficiently. Its customers are medical professionals and healthcare facilities in the United States and other countries.
Intuitive Surgical was founded in 1995 and is headquartered in Sunnyvale, California. Its shares are listed on the NASDAQ under the ticker ISRG.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- intuitive.com
Intuitive Surgical GekkoIndex: the smart money zone
Intuitive Surgical’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.2, in the Neutral zone, down 10.8 points over five sessions.
53.2Neutral
Down 10.8 points over five sessions, from the Accumulation zone.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 34 | +0.9% | +2.8% | ||
| Accumulation | 244 | −0.5% | −0.3% | ||
| Neutral (current zone) | 340 | +0.5% | +0.3% | ||
| Distribution | 43 | −0.6% | +1.1% | ||
| Selling | 1 | Too few readings yet | |||
Average ISRG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ISRG price, zone by zone.Track ISRG in Gekko
Is Intuitive Surgical stock overvalued? Gekko Fair Value
Intuitive Surgical trades 12.3% above Gekko Fair Value of $350.26, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Intuitive Surgical shares are worth, recalculated every trading day.
$350.26
Gekko Fair Value, Sep 19, 2026
12.3% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ISRG in Gekko
Intuitive Surgical insider and Congress trading
No open-market insider purchases were filed for Intuitive Surgical, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ISRG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ISRG, plotted on the chart in Gekko.Open ISRG in Gekko
Buybacks
Intuitive Surgical has been buying back its own shares.
- Latest authorization
- $5.00B, May 4, 2026
- Bought back, quarter ended Jun 30, 2026
- $320.3M
- As a share of market cap
- 0.23%
- Trailing four quarters
- $3.56B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
4of the funds Gekko tracks hold ISRG.
1added1opened2trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Intuitive Surgical earnings: next date and track record
Intuitive Surgical reports on Oct 20, 2026, after the close (30 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Oct 20, 2026
Expected after the close, 30 days away
- EPS estimate
- $2.61
- Revenue estimate
- $2.91B
8 of 8reports beat the EPS estimate
±6.3%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 16, 2026 AI summary
- What they said
- ISRG reported Q2 with total procedures up 16%, da Vinci procedures +15%, and ION procedures +36%. Global installed base grew 12% (da Vinci) and 21% (ION), reaching ~13,000 systems worldwide. US da Vinci growth moderated to 12% amid patient coverage/deferral headwinds. International growth was strong at 20%, though China remains challenged. Q2 system placements were 468 da Vinci and 55 ION units.
- Guidance
- Management updated 2026 financial outlook acknowledging US procedure growth moderation from deferred elective procedures. International markets, particularly Japan policy tailwinds and India da Vinci 5 clearance, are expected to offset some US softness.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 16, 2026 | $2.80 est $2.02 | $2.89B est $2.83B | −11.2% |
| Apr 21, 2026 | $2.50 est $2.12 | $2.77B est $2.62B | +3.9% |
| Jan 22, 2026 | $2.53 est $2.27 | $2.87B est $2.76B | +0.1% |
| Oct 21, 2025 | $2.40 est $1.99 | $2.51B est $2.41B | +15.0% |
| Jul 22, 2025 | $2.19 est $1.93 | $2.44B est $2.35B | −2.7% |
| Apr 22, 2025 | $1.81 est $1.74 | $2.25B est $2.19B | +4.2% |
| Jan 23, 2025 | $2.21 est $1.76 | $2.41B est $2.25B | −4.3% |
| Oct 17, 2024 | $1.84 est $1.63 | $2.04B est $2.01B | +9.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Intuitive Surgical stock forecast and analyst price targets
Analysts’ average 12-month price target for Intuitive Surgical is $476.34, +21.1% from the last close, from 22 firms rating the stock in the last 90 days.
$476.34consensus 12-month target, +21.1% from the last close
Now $393.33Avg $476.34
Low $391High $685
Each firm’s latest rating in the last 90 days: 22 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 14 | Bank of America Securities | $470 | +19.5% |
| Sep 7 | BTIG | $469 | +19.2% |
| Aug 28 | BMO Capital | — | — |
| Aug 21 | Piper Sandler | $470 | +19.5% |
| Aug 13 | Citi | $500 | +27.1% |
+0.3%average 20-day move after past Neutral readings
−3.0%average move over the next 20 trading days in the last 5 years
±3.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Intuitive Surgical seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Intuitive Surgical averaged −3.0% across the last 5 years, rising in 1 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.8% | 2 of 5 |
| Next 10 trading days | −1.7% | 2 of 5 |
| Next 15 trading days | −2.6% | 1 of 5 |
| Next 20 trading days | −3.0% | 1 of 5 |
| Next 30 trading days | +8.6% | 4 of 5 |
For scale, ISRG’s typical 20-trading-day move in either direction is about 6.3%.
Intuitive Surgical market cap and key statistics
Intuitive Surgical’s market cap is $139.0B, with a P/E ratio of 43.9 and revenue of $11.03B over the last twelve months.
Valuation
- Market cap
- $139.0B
- P/E ratio
- 43.9
- Forward P/E
- 31.7
- EPS, TTM
- $8.74
- Gekko Fair Value
- $350.26
Trading
- Volume
- 4.78M
- Avg volume, 20 days
- 2.29M
- 52-week high
- $603.88
- 52-week low
- $328.57
- Shares outstanding
- 358.3M
Financials
- Revenue, TTM
- $11.03B
- Profit margin
- 28.4%
- Return on equity
- 17.4%
- Quarterly earnings growth, YoY
- +26.5%
Risk and income
- Beta
- 1.47
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±6.3%
Intuitive Surgical stock news this week
Coverage of Intuitive Surgical this week reads positive: 5 positive, 2 neutral and 0 negative headlines.
- What Is Driving Attention to Intuitive Surgical (NASDAQ:ISRG)?Kalkine Media, Sep 18
- ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic ProceduresZacks Investment Research, Sep 16
- Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research, Sep 16
- Intuitive single-port robot earns CE mark for new indicationMedTech Dive, Sep 15
- ISRG's da Vinci Study Shows Better Outcomes Across 13 Common ConditionsZacks Investment Research, Sep 15
- Intuitive Surgical Inc. stock underperforms Monday when compared to competitors despite daily gainsMarketWatch, Sep 14
Intuitive Surgical peers
Intuitive Surgical’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 17.1% above |
| ABTAbbott Laboratories | Accumulation | 15.5% below |
| DHRDanaher | Neutral | 1.1% above |
| MDTMedtronic | Neutral | 24.7% below |
| SYKStryker | Buying | 17.1% below |
| BSXBoston Scientific | Accumulation | 35.9% below |
A peer links to its own page where one exists.
Intuitive Surgical stock FAQ
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $139.0B at the Sep 18, 2026 close of $393.33, with 358.3M shares outstanding. The shares trade on a P/E ratio of 43.9.
What is the Intuitive Surgical stock forecast?
The consensus analyst 12-month price target for Intuitive Surgical is $476.34, +21.1% from the last close. Of the 22 firms that rated the stock in the last 90 days, 19 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Intuitive Surgical stock overvalued or undervalued?
On Gekko’s estimate Intuitive Surgical is overvalued: the Sep 18, 2026 close of $393.33 is 12.3% above Gekko Fair Value of $350.26. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Intuitive Surgical report earnings next?
Intuitive Surgical is expected to report on Oct 20, 2026, after the market closes (30 days away). Analysts expect earnings of $2.61 per share on revenue of $2.91B. Intuitive Surgical beat the earnings estimate in 8 of its last 8 reports, moving 6.3% on average across the report.
What is Intuitive Surgical’s 52-week high and low?
Intuitive Surgical’s 52-week high is $603.88 and its 52-week low is $328.57; it closed at $393.33 on Sep 18, 2026, −9.3% over the past year.
Is Intuitive Surgical stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (earnings risk), 2 as mixed (trend and gekkoindex) and 2 as headwinds (fair value and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Intuitive Surgical the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.